BeOne Medicines
ONC
#780
Rank
ยฃ23.26 B
Marketcap
ยฃ224.22
Share price
-3.77%
Change (1 day)
32.33%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Market capitalization of BeOne Medicines (ONC)

Market cap: ยฃ23.26 Billion

As of May 2026 BeOne Medicines has a market cap of ยฃ23.26 Billion. This makes BeOne Medicines the world's 780th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BeOne Medicines from 2016 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ23.26 B-9.37%
2025ยฃ25.66 B57.28%
2024ยฃ16.32 B5.47%
2023ยฃ15.47 B-26.4%
2022ยฃ21.02 B2.11%
2021ยฃ20.58 B18.57%
2020ยฃ17.36 B122.85%
2019ยฃ7.79 B18.35%
2018ยฃ6.58 B99.94%
2017ยฃ3.29 B237.3%
2016ยฃ0.97 B

End of Day market cap according to different sources

On May 13th, 2026 the market cap of BeOne Medicines was reported to be:

ยฃ25.90 Billion
by Nasdaq info icon info icon
ยฃ24.17 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
OPKO Health
OPK
ยฃ0.61 B-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
ยฃ15.38 M-99.93%๐Ÿ‡บ๐Ÿ‡ธ USA